Drug Information

Drug General Information
Drug ID
D0T4HH
Former ID
DPR000093
Drug Name
PT-15
Drug Type
Small molecular drug
Indication Sexual dysfunction; Obesity [ICD9: 278, 302.7; ICD10:E66, F52] Preclinical [536122]
Company
Palatin
Structure
Download
2D MOL

3D MOL
Formula
Na
Canonical SMILES
[Na]
InChI
1S/Na
InChIKey
KEAYESYHFKHZAL-UHFFFAOYSA-N
PubChem Compound ID
5360545
PubChem Substance ID
5326610, 8146756, 10534514, 15170295, 15237733, 24845275, 24848128, 24853383, 24854694, 24855921, 24857014, 24857016, 24868737, 24871915, 24881721, 24886151, 24886235, 24888697, 33088985, 39384005, 50046431, 50074094, 53788965, 57362018, 57647078, 57648086, 57652275, 57652326, 77905220, 83620210, 88826695, 114148349, 117376386, 125809647, 126675963, 131325865, 134339053, 134339153, 134339154, 134339155, 134339359, 134339385, 134339536, 134339884, 134340144, 134987874, 134988506, 137102243, 137156482, 139072878
Target and Pathway
Target(s) Melanocortin-4 receptor Target Info Agonist [536122]
KEGG Pathway Neuroactive ligand-receptor interaction
Pathway Interaction Database Syndecan-3-mediated signaling events
Reactome Peptide ligand-binding receptors
G alpha (s) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.